China Nonalcoholic Steatohepatitis Therapeutics Market (2025-2031) | Outlook, Trends, Growth, Segmentation, Value, Share, Analysis, Industry, Forecast, Size & Revenue, Competitive Landscape, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 China Nonalcoholic Steatohepatitis Therapeutics Market - Industry Life Cycle

3.4 China Nonalcoholic Steatohepatitis Therapeutics Market - Porter's Five Forces

3.5 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of nonalcoholic steatohepatitis (NASH) in China

4.2.2 Growing awareness about the disease and its potential complications

4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China

4.3 Market Restraints

4.3.1 Lack of specific approved therapies for NASH in China

4.3.2 High cost associated with NASH therapeutics

4.3.3 Regulatory challenges and delays in drug approvals in the Chinese market

6.1 China Nonalcoholic Steatohepatitis Therapeutics Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Obeticholic Acid (OCA), 2021- 2031F

6.1.4 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Aramchol (Arachidyl Amido Cholanoic Acid), 2021- 2031F

6.1.5 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Saroglitazar, 2021- 2031F

6.1.6 China Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Elafibranor, 2021- 2031F

7.1 China Nonalcoholic Steatohepatitis Therapeutics Market Export to Major Countries

7.2 China Nonalcoholic Steatohepatitis Therapeutics Market Imports from Major Countries

8.1 Number of clinical trials for NASH therapeutics in China

8.2 Adoption rate of lifestyle modifications and preventive measures for NASH

8.3 Investment in research and development of NASH treatments in China

9.1 China Nonalcoholic Steatohepatitis Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10.1 China Nonalcoholic Steatohepatitis Therapeutics Market Revenue Share, By Companies, 2024

10.2 China Nonalcoholic Steatohepatitis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters